1. Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial. Issue 5 (May 2021) Authors: Risitano, Antonio M; Röth, Alexander; Soret, Juliette; Frieri, Camilla; de Fontbrune, Flore Sicre; Marano, Luana; Alashkar, Ferras; Benajiba, Lina; Marotta, Serena; Rozenberg, Izabela; Milojevic, Julie; End, Peter; Nidamarthy, Prasanna K; Junge, Guido; Peffault de Latour, Régis Journal: Lancet Issue: Volume 8:Issue 5(2021) Page Start: e344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Issue 2 (February 2017) Authors: Chapman, William C.; Brown, Robert S.; Chavin, Kenneth D.; Sudan, Debra; Koneru, Baburao; Junge, Guido; Dong, Gaohong; Patel, Dharmesh; Teperman, Lewis; Fung, John J. Journal: Transplantation Issue: Volume 101:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FC 036IPTACOPAN (LNP023): A NOVEL ORAL COMPLEMENT ALTERNATIVE PATHWAY FACTOR B INHIBITOR SAFELY AND EFFECTIVELY STABILISES EGFR IN C3 GLOMERULOPATHY. (29th May 2021) Authors: Wong, Edwin Kwan Soon; Praga, Manuel; Nester, Carla; Le Quintrec, Moglie; Daina, Erica; Remuzzi, Giuseppe; Trapani, Angelo; Wang, Yaqin; Liu, Junhao; Junge, Guido; Meier, Matthias; Webb, Nicholas Journal: Nephrology dialysis transplantation Issue: Volume 36(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity. Issue 1 (December 2015) Authors: Nirmala, Nanguneri; Brachat, Arndt; Feist, Eugen; Blank, Norbert; Specker, Christof; Witt, Matthias; Zernicke, Jan; Martini, Alberto; Junge, Guido Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MO042LNP023: A NOVEL ORAL COMPLEMENT ALTERNATIVE PATHWAY FACTOR B INHIBITOR FOR THE TREATMENT OF GLOMERULAR DISEASE. (6th June 2020) Authors: Webb, Nicholas; Haraldsson, Boerje; Schubart, Anna; Milojevic, Julie; End, Peter; Holbro, Thomas; Junge, Guido Journal: Nephrology dialysis transplantation Issue: Volume 35(2020)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Open‐Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome. Issue 8 (5th July 2017) Authors: Arostegui, Juan I.; Anton, Jordi; Calvo, Inmaculada; Robles, Angel; Iglesias, Estibaliz; López‐Montesinos, Berta; Banchereau, Romain; Hong, Seunghee; Joubert, Yolandi; Junge, Guido; Pascual, Virginia; Yagüe, Jordi Journal: Arthritis & rheumatology Issue: Volume 69:Issue 8(2017) Page Start: 1679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial. Issue 10320 (8th January 2022) Authors: Bowman, Simon J; Fox, Robert; Dörner, Thomas; Mariette, Xavier; Papas, Athena; Grader-Beck, Thomas; Fisher, Benjamin A; Barcelos, Filipe; De Vita, Salvatore; Schulze-Koops, Hendrik; Moots, Robert J; Junge, Guido; Woznicki, Janice N; Sopala, Monika A; Luo, Wen-Lin; Hueber, Wolfgang Journal: Lancet Issue: Volume 399:Issue 10320(2022) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus. Issue 7 (July 2015) Authors: Fischer, Lutz; Saliba, Faouzi; Kaiser, Gernot M.; De Carlis, Luciano; Metselaar, Herold J.; De Simone, Paolo; Duvoux, Christophe; Nevens, Frederik; Fung, John J.; Dong, Gaohong; Rauer, Barbara; Junge, Guido Journal: Transplantation Issue: Volume 99:Issue 7(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. Issue 7 (July 2015) Authors: Fischer, Lutz; Saliba, Faouzi; Kaiser, Gernot M.; De Carlis, Luciano; Metselaar, Herold J.; De Simone, Paolo; Duvoux, Christophe; Nevens, Frederik; Fung, John J.; Dong, Gaohong; Rauer, Barbara; Junge, Guido Journal: Transplantation Issue: Volume 99:Issue 7(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗